An interesting analysis of the stock market’s reaction to Jacob Thaysen’s appointment as Illumina’s new CEO. What could be the potential impact on Illu...
An interesting analysis of the stock market’s reaction to Jacob Thaysen’s appointment as Illumina’s new CEO. What could be the potential impact on Illu...
Retail veteran Rosalind Brewer Walgreens is out as Walgreens CEO after more than two years in the job. Walgreens Boots Alliance said Friday that Roz Brewer had stepp...
As per the report, Bayer split call for change joins a growing chorus of demands for transformation from various other Bayer investors. Earlier this year, activist s...
Court on Thursday agreed to hear a challenge by President Joe Biden’s administration to the legality of OxyContin maker Purdue Pharma’s bankruptcy settle...
Rakesh Jhunjhunwala backed Concord Biotech IPO will be the second in the mainboard segment, opening for subscription this week after SBFC Finance. ...
In a statement Novartis raised it stock outlook for a second time from a prior estimate of high single-digits gains. ...
FTC is geared up to unhesitantly scrutinize and challenge pharmaceutical conglomerates that could entrench their monopolies. ...
Novartis has named the intended new board members of Sandoz, the generics business it plans to spin off to shareholders later this year. The move is a key step in th...
While the US IPO market has been quite quiescent in 2022, J&J’s Kenvue is expected to renew the hopes of other companies that were holding their IPOs in abeyan...